company score funding investors employees industries biz model city contact
Causaly

Biomedical research discovery tool.

64
$60M · Series B ICONIQ Growth, Index Ventures, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
Apollo Therapeutics

Portfolio of pharmaceutical research and discovery.

64
$33M · Series C Patient Square Capital, Rock Springs Capital, M&G Investments 1 to 10 Biotech, Pharma London, UK •••••••••••@apollotherapeutics.com
Calluna Pharma

Developer of therapies for inflammatory and fibrotic diseases.

64
$81M · Series A Sarsia, p53, Forbion Capital Partners 11 to 50 Biotech, Pharma Oslo, Norway •••••••••••@callunapharma.com
Enterome

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

54
$3M · Series F The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Paris, France •••••••••••@enterome.com
Pear Bio

Cancer treatment predictor software.

54
$14M · Series A Hoxton Ventures, Octopus Ventures, Fly Ventures 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@pearbio.com
ReViral

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

54
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
SafeHeal

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

54
$47M Sofinnova Partners 1 to 10 Health Tech, Hardware, Pharma, Manufacturing B2B Paris, France •••••••••••@safeheal.com
Xund HIRING

We enable healthcare companies to digitize patient interactions and translate data into actionable insights.

54
$2M · Seed Thieme, MassMutual Ventures, MMC Ventures 11 to 50 Health Tech, AI, Insuretech, Pharma, Business Intelligence B2B, SaaS Vienna, Austria •••••••••••@xund.ai
Flarin

Patent-protected anti-inflammatory painkiller.

54
$6M · Series A ITV AdVentures 1 to 10 Biotech, Pharma B2C London, UK •••••••••••@flarin.co.uk
ADmit Therapeutics

Early detection of Alzheimer's disease (AD) technology.

50
$5M · Series A EIC Accelerator, WA4STEAM, Ship2B 1 to 10 Health Tech, Biotech, Pharma B2B Barcelona, Spain •••••••••••@admit-therapeutics.com
Bactolife

Producer of gut health binding proteins.

50
$32M · Series A Bill & Melinda Gates Foundation, Novo A/S 1 to 10 Biotech, Pharma B2B Copenhagen, Denmark •••••••••••@bactolife.com
Charac

The Charac app streamlines access to your local pharmacy. Skip the queue, save time and access all of your prescriptions from anywhere.

50
$1M · Seed NPA, MedAdvisor 1 to 10 Pharma, Mobile, Ecommerce B2C, Marketplace London, UK •••••••••••@charac.co.uk
Ermium Therapeutics

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

50
$6M · Series A Fountain Healthcare Partners 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@ermium.com
Hemab

Treatments for genetic bleeding disorders.

50
$135M · Series B Novo A/S, HealthCap 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Copenhagen, Denmark •••••••••••@hemab.com
Lyphe group

Lyphe group is a reliable supplier of medical cannabis care and medicine.

50
$6M · Series A Leafy Tunnel 51 to 100 Health Tech, Agritech, Pharma, Manufacturing, Cannabis B2B London, UK •••••••••••@LYPHEGROUP.com
Manual

Manual provides diagnostic tools and testing to help patients make health-related decisions.

50
$6M · Seed Felix Capital, Cherry Ventures, FJ Labs 11 to 50 Health Tech, Fashion, Pharma, Mobile, Ecommerce B2C London, UK •••••••••••@manual.co
Myricx Pharma

Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.

50
$6M · Seed Sofinnova Partners 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@myricxpharma.com
Qubit Pharmaceuticals

Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.

50
$17M · Seed Quantonation, XAnge 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Paris, France •••••••••••@qubit-pharmaceuticals.com
Iktos

AI drug discovery platform.

50
$16M · Series A M Ventures 11 to 50 Pharma Paris, France •••••••••••@iktos.ai
SkyCell

Temperature controlled containers for the pharmaceutical industry.

46
$57M · Series C M&G Investments, MVM Life Science Partners 101 to 250 Pharma, Manufacturing B2B Zürich, Switzerland •••••••••••@skycell.ch
Vico Therapeutics

Medicine for rare neurological diseases.

46
$59M · Series B Idinvest Partners, EQT Life Sciences, Droia Ventures 11 to 50 Biotech, Pharma B2C The Hague, Netherlands •••••••••••@vicotx.com
Castor EDC

Cloud-based clinical data platform.

43
$6M · Seed Eight Roads Ventures, Inkef Capital 101 to 250 Health Tech, Biotech, Pharma B2B, SaaS Amsterdam, Netherlands •••••••••••@castoredc.com
CimCure

CimCure focuses on design and development of a novel class of active cancer immunotherapies.

43
$5M · Seed Positron Ventures Health Tech, Biotech, Pharma B2B Amsterdam, Netherlands •••••••••••@cimcure.com
Core Biogenesis

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

43
$3M · Seed Entrepreneur First, Thia Ventures, XAnge 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Paris, France •••••••••••@corebiogenesis.com
Epsilogen

Immuno-oncology company treats cancer with antibodies.

43
$2M · Series A AlbionVC, Novartis Venture Fund, Epidarex Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics B2B London, UK •••••••••••@epsilogen.com
Gesynta Pharma

Developer of therapies for treating chronic inflammatory conditions.

43
$6M · Seed Industrifonden, Hadean Ventures 1 to 10 Health Tech, Pharma B2B Stockholm, Sweden •••••••••••@gesynta.se
HMNC Brain Health

HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.

43
$10M ALSTIN Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Munich, Germany •••••••••••@hmnc-brainhealth.com
Kayentis

Data capture for clinical trials.

43
$2M · Seed Bpifrance 11 to 50 Health Tech, Pharma, Data and Analytics B2B, SaaS Paris, France •••••••••••@kayentis.com
Octarine Bio

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

43
$4M · Series A Unconventional Ventures, The Footprint Firm, Oskare Capital 1 to 10 Health Tech, Biotech, Pharma, Manufacturing B2B Copenhagen, Denmark •••••••••••@octarinebio.com
Peptone

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

43
$2M Hoxton Ventures, Bessemer Venture Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B London, UK •••••••••••@peptone.io
Precirix

Manufacturer of radio-immunotherapeutic drugs for cancer patients.

43
$40M · Series A Novo A/S, Forbion Capital Partners, BioMedPartners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Brussels, Belgium •••••••••••@precirix.com
Step Pharma

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

43
$2M · Seed Bpifrance, Idinvest Partners, AGORANOV 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@step-ph.com
NK:IO

Immunotherapy for the treatment of cancer.

43
$1M · Seed Cancer Research Horizons, UK Innovation & Science Seed Fund 11 to 50 Biotech, Pharma B2C London, UK •••••••••••@nk-io.com
VRG Therapeutics

Biotech R&D specializing in miniprotein-based pharmaceuticals and cellular & gene therapy (CGT) products

43
$5M · Series A Széchenyi Capital Fund Management 11 to 50 Biotech, Pharma Budapest, Hungary •••••••••••@vrgtherapeutics.com
Beckley Psytech

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

42
$40M · Series B Leafy Tunnel, ATAI Life Sciences 1 to 10 Biotech, Pharma B2C Oxford, UK •••••••••••@beckleypsytech.com
Amadix

Early cancer detection diagnostics platform.

39
$3M Inveready 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Madrid, Spain •••••••••••@amadix.com
AptaTargets

Therapeutics treatment for strokes and brain injury.

39
$2M · Series A Caixa Capital Risc, Inveready 1 to 10 Health Tech, Biotech, Pharma B2B Madrid, Spain •••••••••••@aptatargets.com
Biosyntia

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.

39
$11M · Series B Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Copenhagen, Denmark •••••••••••@biosyntia.com
Devon Labs

Devon Labs solve patients unmet medical and care needs.

39
$4M Inveready 1 to 10 Health Tech, Pharma B2B Madrid, Spain •••••••••••@devonlabs.com
Exogene

Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.

39
$104k · Pre Seed Atomico, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics B2B London, UK •••••••••••@exogene.co.uk
Fermify

Casein protein manufacturer for animal-free cheese.

39
$5M · Seed Climentum Capital, PUSH Ventures, BackBone Ventures 1 to 10 Foodtech, Biotech, Pharma, Manufacturing B2B Vienna, Austria •••••••••••@fermify.org
Inato

AI-powered data collecting tool for clinical trials.

39
$1M · Seed Kima Ventures, Cathay Innovation, Serena 11 to 50 Health Tech, AI, Biotech, Machine Learning, Pharma B2B, SaaS Paris, France •••••••••••@inato.com
Rappta Therapeutics

Anti-cancer drugs ddevelopers activating protein phosphatase 2A (PP2A)

39
$10M · Series A Novo A/S, Novartis Venture Fund 1 to 10 Health Tech, Biotech, Pharma B2B Helsinki, Finland •••••••••••@rappta-therapeutics.com
Tuli Health

Tuli Health is a digital health platform that provides instant access to private medical appointments and testing.

39
$125k · Pre Seed Y Combinator 1 to 10 Health Tech, CPG & Consumer Goods, Pharma B2B, SaaS London, UK •••••••••••@tuli.health
XO Life

XO Life connects patients and pharma for the better life.

39
$2M · Seed Aescuvest 11 to 50 Health Tech, Pharma, Sales and Marketing B2B, Marketplace Munich, Germany •••••••••••@xo-life.com
Actimed Therapeutics

Developer of innovative treatment for muscle wasting disorders.

39
$1M · Seed Mankind Pharma 1 to 10 Biotech, Pharma London, UK •••••••••••@actimedtherapeutics.com
Measurlabs

Testing and certifications platform for any material, product or chemical.

39
$2M · Seed VentureFriends, Lifeline Ventures 11 to 50 Biotech, Pharma Helsinki, Finland •••••••••••@measurlabs.com
AbolerIS Pharma

AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.

37
$29M · Series A Caixa Capital Risc, Sound Bioventures 1 to 10 Health Tech, Biotech, Pharma B2B Nantes, France •••••••••••@aboleris-pharma.com
Anjarium Biosciences

Gene therapy research to tackle genetic diseases.

37
$59M · Series A Gimv 1 to 10 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@anjarium.com
Cardior Pharmaceuticals

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

37
$76M BioMedPartners, High-Tech Gründerfonds, Hadean Ventures 11 to 50 Health Tech, Biotech, Pharma B2B Hanover, Germany •••••••••••@cardior.de
Emergence Therapeutics

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

37
$99M High-Tech Gründerfonds, Hadean Ventures 1 to 10 Health Tech, Biotech, Pharma, Fitness, Manufacturing B2B Duisburg, Germany •••••••••••@emergencetx.com
F2G

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

37
$70M Sofinnova Partners, Novo A/S, Forbion Capital Partners 251 to 500 Health Tech, Biotech, Pharma, Genetics B2B Manchester, UK •••••••••••@f2g.com
Healx

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

37
$56M · Series B Balderton Capital, Atomico, Amadeus Capital 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
ImCheck Therapeutics

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

37
$102M Eurazeo, Earlybird Venture Capital, Andera Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Marseille, France •••••••••••@imchecktherapeutics.com
Noema Pharma

Clinical-stage central nervous system (CNS) technology.

37
$110M · Series B Sofinnova Partners, Forbion Capital Partners, BioMedPartners 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@noemapharma.com
Osler Diagnostics

Lab-quality diagnostics for anyone, anywhere, at any time.

37
$85M Oxford Science Enterprises 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Oxford, UK •••••••••••@oslerdiagnostics.com
Oxford Nanopore Technologies

Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.

37
$275M Wellington Management 251 to 500 Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics B2B Oxford, UK •••••••••••@nanoporetech.com
Alex Therapeutics

AI-powered CBT therapeutic platform.

34
$130k · Pre Seed Scale Capital, Hadean Ventures, Sweet Studio 1 to 10 Health Tech, AI, Pharma, Ecommerce B2B, Marketplace Stockholm, Sweden •••••••••••@alextherapeutics.com
Climedo

Climedo's platform enables cutting-edge clinical validation and product surveillance of medical devices and pharmaceutical products

34
$1M · Pre Seed Nauta Capital 51 to 100 Health Tech, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Munich, Germany •••••••••••@climedo.de
Hemispherian

Pre-clinical platform for all kinds of cancer treatment.

34
$3M Investinor 1 to 10 Health Tech, Biotech, Pharma B2B Oslo, Norway •••••••••••@hemispherian.com
Inossia

Inossia provides a softener to make bone cements better suited to the mechanical properties of osteoporotic bone.

34
$330k · Pre Seed Almi Invest 1 to 10 Health Tech, Hardware, Pharma B2B Stockholm, Sweden •••••••••••@inossia.com
MiNA Therapeutics

MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms.

34
$29M 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Genetics B2B London, UK •••••••••••@minatx.com
Muna Therapeutics

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

34
$2M Sofinnova Partners, Novo A/S, V-Bio Ventures Health Tech, Biotech, Pharma B2B Copenhagen, Denmark •••••••••••@munatherapeutics.com
Nanoligent

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

34
$1M · Seed i&i Biotech Fund Health Tech, Biotech, Pharma, Robotics, Manufacturing B2B Barcelona, Spain •••••••••••@nanoligent.com
Ona Therapeutics

Therapeutic biologics platform to treat metastatic cancer.

34
$1M · Seed Ysios Capital, Asabys Partners 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Barcelona, Spain •••••••••••@ona-therapeutics.com
Pangaea Data

Pangaea Data provides a machine learning-based software solution making scientific and clinical data more meaningful.

34
N/A Ascension Ventures, Hambro Perks Ltd., IQ Capital Partners 1 to 10 Health Tech, AI, Machine Learning, Pharma, Data and Analytics, Business Intelligence B2B, SaaS London, UK •••••••••••@pangaeadata.ai
Pheon Therapeutics

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

34
N/A Forbion Capital Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@pheontx.com
Synthace

Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.

34
N/A Sofinnova Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things B2B, SaaS London, UK •••••••••••@synthace.com
TIRmed Pharma

TIRmed Pharma develops drug candidates addressing major clinical needs.

34
$630k · Seed Almi Invest 1 to 10 Health Tech, Pharma B2B Stockholm, Sweden •••••••••••@tirmedpharma.com
OTHER INDUSTRIES
Other Pharma startups by location